Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Todd M Bull

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Hepatology (Baltimore, Md.)|May 15, 2020
Estrogen Signaling and Portopulmonary Hypertension: The Pulmonary Vascular Complications of Liver Disease Study (PVCLD2)Nadine Al-Naamani, Michael J Krowka, Kimberly A Forde, et al.
Nature Communications|May 31, 2017
TGF-β activation by bone marrow-derived thrombospondin-1 causes Schistosoma- and hypoxia-induced pulmonary hypertensionRahul Kumar, Claudia Mickael, Biruk Kassa, et al.
Pulmonary Circulation|October 21, 2021
Health-related quality of life and hospitalizations in chronic thromboembolic pulmonary hypertension versus idiopathic pulmonary arterial hypertension: an analysis from the Pulmonary Hypertension Association Registry (PHAR)Jasleen Minhas, Sai Prasanna Narasimmal, Todd M Bull, et al.
Pulmonary Circulation|December 21, 2022
Erratum: Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: An analysis of the Pulmonary Hypertension Association RegistryHilary M DuBrock, Charles D Burger, Sonja D Bartolome, et al.
Pulmonary Circulation|June 23, 2021
Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: an analysis of the Pulmonary Hypertension Association RegistryHilary M DuBrock, Charles D Burger, Sonja D Bartolome, et al.
Chest|September 30, 2021
Study of Alteplase for Respiratory Failure in SARS-CoV-2 COVID-19: A Vanguard Multicenter, Rapidly Adaptive, Pragmatic, Randomized Controlled TrialChristopher D Barrett, Hunter B Moore, Ernest E Moore, et al.
American Journal of Respiratory and Critical Care Medicine|April 22, 2017
Enhancing Insights into Pulmonary Vascular Disease through a Precision Medicine Approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop ReportJohn H Newman, Stuart Rich, Steven H Abman, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Hepatology (Baltimore, Md.)|May 15, 2020
Estrogen Signaling and Portopulmonary Hypertension: The Pulmonary Vascular Complications of Liver Disease Study (PVCLD2)Nadine Al-Naamani, Michael J Krowka, Kimberly A Forde, et al.
Nature Communications|May 31, 2017
TGF-β activation by bone marrow-derived thrombospondin-1 causes Schistosoma- and hypoxia-induced pulmonary hypertensionRahul Kumar, Claudia Mickael, Biruk Kassa, et al.
Pulmonary Circulation|October 21, 2021
Health-related quality of life and hospitalizations in chronic thromboembolic pulmonary hypertension versus idiopathic pulmonary arterial hypertension: an analysis from the Pulmonary Hypertension Association Registry (PHAR)Jasleen Minhas, Sai Prasanna Narasimmal, Todd M Bull, et al.
Pulmonary Circulation|December 21, 2022
Erratum: Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: An analysis of the Pulmonary Hypertension Association RegistryHilary M DuBrock, Charles D Burger, Sonja D Bartolome, et al.
Pulmonary Circulation|June 23, 2021
Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: an analysis of the Pulmonary Hypertension Association RegistryHilary M DuBrock, Charles D Burger, Sonja D Bartolome, et al.
Chest|September 30, 2021
Study of Alteplase for Respiratory Failure in SARS-CoV-2 COVID-19: A Vanguard Multicenter, Rapidly Adaptive, Pragmatic, Randomized Controlled TrialChristopher D Barrett, Hunter B Moore, Ernest E Moore, et al.
American Journal of Respiratory and Critical Care Medicine|April 22, 2017
Enhancing Insights into Pulmonary Vascular Disease through a Precision Medicine Approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop ReportJohn H Newman, Stuart Rich, Steven H Abman, et al.
Pageof 7